Privi Speciality Chemicals Ltd (NSE:PRIVISCL)

Q3 2026 Privi Speciality Chemicals Ltd Earnings Call Transcript

Feb 10, 2026 / 10:30 AM GMT

Release Date Price: ₹2740.4 (-0.50%)

Transcript

Key Points

Positve

Privi Speciality Chemicals Ltd (BOM:530117) reported a strong revenue growth of 24% year-on-year for both Q3 and the nine-month period of FY26.
The company has maintained a robust EBITDA margin of 25% for the third consecutive quarter, showcasing operational efficiency.
A strategic expansion plan is in place to increase production capacity by 55% over the next 2-3 years, aligning with long-term growth objectives.
The joint venture with Javaran Prijev is progressing well, with positive EBITDA achieved in Q3 and expectations of net profit in the next financial year.
Privi Speciality Chemicals Ltd (BOM:530117) is benefiting from favorable trade conditions, particularly with the EU and US, enhancing its competitive advantage over other countries like China.

Negative

The company faces geopolitical uncertainties and tariff-related challenges that could impact global trade and business operations.
There is a potential risk of stabilization issues with new product facilities, which may affect revenue growth in the short term.
The company has not recognized any state incentives this quarter, which could impact financial performance.
There is a cautious outlook on maintaining EBITDA margins above 20%, with potential fluctuations due to global market uncertainties.
The merger process with Privi Fine Sciences Private Limited and Privi Biotechnologies Limited is expected to take up to a year, delaying potential synergies and financial consolidation.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PIVI.NS - Privi Speciality Chemicals Ltd
Q3 2026 Privi Speciality Chemicals Ltd Earnings Call
Feb 10, 2026 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Prev Specialty Chemicals Q3 and 9 month FY26 earnings conference call. This conference call may contain forward-looking statements about the company which are based on the beliefs, opinions, and expectations of the company as on the date of this call. These statements are not guarantees of future performance and involves risks and uncertainties that are difficult to predict. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing, then 0 on your touchstone phone.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.